|
|
TAKING carbidopa/levodopa
STALEVO is indicated for
certain patients with Parkinson's disease experiencing symptom
re-emergence due to wearing-off.
|
|
|
|
|
Carbidopa/levodopa is the mainstay of treatment for people with Parkinson's disease (PD).
|
|
|
While carbidopa/levodopa is an effective treatment for Parkinson's disease symptoms, PD
is a condition for which currently there is no cure. Symptoms advance from early to
moderate to advanced stages. As PD progresses, a dose of medication that was effective
may "wear off" before the next scheduled dose, and symptoms may re-emerge. As symptoms
progress, your treatment may need to be modified.
|
|
|
Find out more about symptom re-emergence.
|
|
|
If you are on levodopa therapy and experiencing symptom re-emergence due to wearing-off,
it may be time to ask about STALEVO.
|
|
|
|
Find out how to talk to your healthcare provider.
|
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
|
Learn more about the progression of Parkinson's disease
|
|
|
|
| |
 |
|
|
|
|
|
Read about treatment options for Parkinson's disease.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
 |
|
| Sinemet is a registered trademark of Merck & Co. |
| |
| |
|
|
|
 |
Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ®2010 Novartis Pharmaceuticals Corporation. All rights reserved. |
| |
|
|
| |
|
